| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
3,421 |
1,787 |
$652K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
1,278 |
741 |
$336K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
509 |
272 |
$59K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
53 |
39 |
$43K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
683 |
542 |
$41K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
73 |
66 |
$15K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
246 |
163 |
$12K |
| 80050 |
General health panel |
186 |
142 |
$10K |
| 80053 |
Comprehensive metabolic panel |
707 |
603 |
$9K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
41 |
33 |
$8K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
763 |
658 |
$7K |
| 86140 |
|
509 |
430 |
$6K |
| 36415 |
Collection of venous blood by venipuncture |
1,326 |
1,065 |
$6K |
| J3490 |
Unclassified drugs |
1,018 |
419 |
$3K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
48 |
47 |
$3K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
24 |
12 |
$2K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
14 |
12 |
$2K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
62 |
31 |
$2K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
39 |
37 |
$2K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
31 |
24 |
$2K |
| 84443 |
Thyroid stimulating hormone (TSH) |
14 |
12 |
$994.08 |
| 84703 |
|
38 |
26 |
$921.63 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
28 |
28 |
$474.39 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
14 |
14 |
$339.36 |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
33 |
27 |
$318.17 |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
41 |
27 |
$246.81 |
| 81003 |
|
47 |
29 |
$127.99 |
| 83735 |
|
20 |
14 |
$48.44 |
| 81001 |
|
16 |
12 |
$40.50 |
| 84100 |
|
20 |
14 |
$34.30 |
| 85652 |
|
12 |
12 |
$18.60 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
13 |
12 |
$11.20 |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
21 |
13 |
$0.00 |